Información:
Error:
Palabras clave
GIPOGONADIZM ×
- Clinical Trial (163)
- Testosterone (162)
- Drug trial (38)
- Vital Signs (22)
- Laboratories (21)
- Treatment Form (18)
- Electrocardiogram (ECG) (18)
- Urinalysis (17)
- Hematology (16)
- Clinical Chemistry Tests (15)
- Drugs, Investigational (14)
- Physical Examination (12)
- Consent Forms (12)
- Pharmacokinetics (11)
- Blood (11)
- Substance Abuse Detection (9)
- Urine (8)
- Trial screening (8)
- Adverse event (5)
- End of Study (4)
- Eligibility Determination (4)
- Hematologic Tests (3)
- Pharmacogenetics (2)
- Research Personnel (2)
- Serology (2)
- Comment (2)
- Prostate-Specific Antigen (2)
- Blood Pressure (2)
- Concomitant Medication (2)
- Demography (2)
- Liver Function Tests (2)
- Urology (1)
- Abnormalities, Multiple (1)
- Clinical Trial, Phase I (1)
- Chemistry, Clinical (1)
- Lost to Follow-Up (1)
- Cotinine (1)
- Disease (1)
- Electrocardiography (1)
- Follow-Up Studies (1)
- Medical Records (1)
- Patient Admission (1)
Tabla de contenido
Modelos de datos seleccionados
Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.
163 Resultados de la búsqueda.
Itemgroups: Administrative documentation, Serious Adverse Event
Itemgroups: Administrative documentation, Clinical Research, Conclusion
Itemgroups: Administrative documentation, Clinical Investigators. Comment
Itemgroups: Administrative documentation, Clinical Research, Conclusion
Itemgroups: Administrative documentation, Investigator Signature
Itemgroups: Administrative documentation, Concomitant Medications
Itemgroups: Administrative documentation, Experimental drug, Therapeutic Procedure, Confirmation
Itemgroups: Administrative documentation, 12 lead ECG, Abnormality
Itemgroups: Administrative documentation, Experimental drug, Therapeutic Procedure, Confirmation
Itemgroups: Administrative documentation, Experimental drug, Therapeutic Procedure, Confirmation
Itemgroups: Administrative documentation, Concomitant Medications
Itemgroups: Administrative documentation, Serious Adverse Event, Serious Adverse Event, Seriousness of Adverse Event, Serious Adverse Event, Demographics Domain, Serious Adverse Event, Experimental Drug, Serious Adverse Event, Causations, Disease, Serious Adverse Event, Risk Factors, Serious Adverse Event, Concomitant Agent, Investigational New Drugs, Serious Adverse Event, Evaluation, Serious Adverse Event, Comment, Confirmation, Clinical Investigators